Introduction

Nitrones as the 1,3-dipolar species are valuable intermediates in organic synthesis [1]. Thermal cycloaddition reactions of nitrones with multiple bond systems is an efficient strategy for providing various heterocyclic five-membered ring systems [25]. On the other hand, they are source of new heterocyclic compound via ring opening reactions [68]. Under facial concerted [п4s + п2s] cycloaddition reaction, nitrones react with acetylenes and olefins to yield isoxazolines and isoxazolidines, respectively. Furthermore, due to the stability of resulting nitroxide radicals and ease of chemical modification [9], nitrones have important biological activity [1012]. Nitrones are not only useful to understand age-related disease processes but also serendipitously have proven to be candidate for therapeutics in some cases [13]. A number of reports have appeared on the chemistry of 1,3-dipolar species, with special emphasis on their cycloaddition reaction with multiple bonds [14]. The cycloadducts of di- and tri-arylimidazoline-3-oxides [15] with a variety of dipolarophiles [1621] give interesting biologically active heterocyclic compounds [22]. The 1, 3-dipolar cycloaddition of imidazolin-3-oxides was shown to proceed regio- and diasteroselectivity and interesting reactions of these adducts under various conditions such as the double cis elimination they undergo in the presence of dialkylamines was reported [23, 24].

The most common procedures for the preparation of nitrones include oxidation of secondary amines or N,N-disubstituted hydroxylamine or condensation reaction between aldehydes or ketones with N-monosubstituted hydroxylamines [25, 26]. To the best of our knowledge, there are two known cases in the literature reported by G-Q Chen et al. [27, 28] in which 3,4-diaminoglyoxime, DAG, has acted as amine source for the synthesis of nitrones. In those cases the reaction of benzaldehyde derivatives and DAG has been carried out in anhydrous ethanol in the presence of p-toluene sulphonic acid (p-TSA) at 55–65 °C within 6–28 h. Herein, we wish to extend the previously published methodology for the preparation of novel nitrones from DAG and cyclic or acyclic ketones and modify the reaction conditions for both ketones and aldehydes. Accordingly, a modified green method for the reaction of DAG with both benzaldehydes and ketones is reported in H2O/MeOH mixture at room temperature in the presence of a strong acid for much shorter reaction times.

Results and discussion

The chemistry of DAG is of great interest because of the fact that it involves two different reactive functional groups, amine and oxime, that have been repeated twice. One or more functional groups in DAG may react, as expected, with other appropriate functional groups such as aldehydes in different manners and, therefore, totally different products may result. From the theoretical point of view, DAG can perform condensation reaction with aldehyde and ketone in a number of ways. It can react, for instance, (1) in 2:1 molar ratio to get a bis-Schiff bases (I, IV), (2) in 1:1 molar ratio between two NH2 of DAG and –COH to reach five-membered ring heterocycles (II, V) and (3) in 1:1 molar ratio between NH2 and oxime functional groups of DAG and –COH to obtain nitrones (III, VI) as shown in Scheme 1.

Scheme 1
scheme 1

Three logically expected products for each of the reaction of DAG with aldehyde and ketone derivatives

However, it was found that the nitrones are prepared in the presence of p-TSA, as catalyst, under the reaction conditions applied, as shown in Scheme 2.

Scheme 2
scheme 2

Cyclic functionalized nitrones obtained in the reaction of DAG with aldehydes and ketones

The condensation reaction of DAG was initially performed in the absence of p-TSA using benzaldehyde or cyclohexanone in methanol–water (30:70) mixture at room temperature and the progress of the reaction was monitored by TLC. A slow condensation reaction was noticed. Then, they were performed in the presence of p-TSA and, after the completion of the reaction, the corresponding nitrones were isolated as white precipitate within 10–140 min in 83 and 95 %, respectively. It became clear to us that the anhydrous condition is not mandatory, as was applied earlier, and the reaction works well in H2O/MeOH solvent at room temperature. The same procedure was successfully applied to the other aldehydes (2) and ketones (4) and the expected nitrones 3a-i and 5a-e were isolated in good yields (Table 1). It was found that higher yields could be achieved for the aromatic aldehyde derivatives involving electron donating group, as shown in Table 1.

Table 1 Reaction conditions for the synthesis of nitrones 3a-i and 5a-e in H2O/MeOH(70/30) solvent at room temperature

Considering the proposed mechanism by G-Q Chen et al. for the reaction of DAG and benzaldehyde derivatives, we suggest a similar reaction mechanism for ketones as shown in the scheme 3. Firstly, the protonated carbonyl in ketone derivatives is attacked by the nitrogen atom of one of the amino groups of 3,4-diaminoglyoxime 1, and the C=N functional group is formed by deprotonation and dehydration. Subsequently, the nitrogen in the newly formed C=N bond is protonated, followed by the nucleophilic attach by the oxime nitrogen atom, and the five-membered heterocyclic ring is formed. By deprotonation, the final products 5(a-e) are obtained.

Scheme 3
scheme 3

The plausible mechanism for the formation of 2-amino-3-(hydroxyimino)-1,4-diazaspiro [4.5]dec-1-ene 1-oxide from the reaction of cyclohexanone and DAG

The structure of nitrones 3(a-i) and 5(a-e) were determined by IR, 1HNMR, 13CNMR and mass spectra. In the IR spectra 3(a-i) strong absorption bands at 2,883–2,892 cm−1 can be observed which should be assigned to the C–H in imidazole ring and 1,450–1,650 cm−1 for the benzene ring. In addition, in the 13C spectra of nitrones 5(a-e) characteristic peaks in the 80–100 ppm region can be observed, which confirms the presence of spiro carbon of the corresponding nitrones.

The 1HNMR spectrum of 3b before heating at 100 °C exhibited characteristic signals for CH imidazole ring at 5.62, 5.77 ppm, NH2 at 6.40, 6.49 ppm, NH at 7.57, 7.83 ppm, NOH at 10.02, 10.23 ppm and CH aryl hydrogens in the 7.30–7.56 ppm regions. In the 13CNMR spectra, aromatic carbon atoms resonated at 126.9, 127.0, 127.2, 128.1, 128.9, 129.2, 129.4, 129.7, 129.9, 131.3 ppm. Other carbons were observed at 140.1, 141.9 and 145.4 and 152.0 ppm. It is worth to note that the expected peak numbers in 13CNMR spectra are almost double in most of the cases.

The 1HNMR spectrum of 5b exhibited characteristic CH2 signals for cyclohexane ring in the 1.19–1.67 ppm region, NH2 at 5.47, 6.25 ppm, NH at 6.94, 7.76 ppm, NOH at 9.91, 10.07 ppm. In the 13CNMR spectra, spiro carbon appeared at 83.7, 97.6 ppm and carbons of cyclic cyclohexane resonated at 21.2, 22.4, 24.1, 24.3, 34.7, 35.8 ppm. Other carbons were observed at 135.5, 141.8, 143.7 and 150.5 ppm. As noticed for the nitrone products obtained from aldehyde derivatives, the number of 13C peak observed for the nitrones resulted from ketones are almost double of those expected in the static 13C NMR spectra. This might be due to the Z–E isomerization of HO–N=C–NH segment via either tautomerization followed by rotation or nitrogen inversion of the hydroxyimino group shown for 5b. (Scheme 4) Similar isomerization pathway could be considered for the other nitrone derivatives 3 and 5.

Scheme 4
scheme 4

A proposed Z–E isomerization pathway for HO–N=C–NH segment in 5b

To investigate the unexpected number of NMR peaks in the obtained nitrone derivatives, dynamic NMR studies were undertaken. So, the effect of heat treatment on the 1H NMR and 13C NMR spectra was monitored. The 1H– and 13C NMR spectra for 3b and 5b showed the presence of two isomers of nitrones at room temperature. The 1H– and 13C NMR spectra were recorded again after heating the samples at 100 °C for 1 h and cooling down the sample to room temperature. As shown in Fig. 1 and 2, only one isomer was noticed in each case, after heat treatment. This is probably due to the thermal stability of the Z-isomer over the E-isomer of nitrone [27, 28]. Based on the chemical shifts of the observed peaks, after heat treatment, one can specify which set of peaks in the NMR spectra of Z–E mixtures are due to each of the isomers. This method has been followed to analyze the NMR spectral data in “Experimental” section.

Fig. 1
figure 1

1HNMR spectra of 3b before (a) and after (b) heat treatment at 100 °C for 1 h

Fig. 2
figure 2

1HNMR and 13CNMR spectra of 5b before a and after b heat treatment at 100 °C for 1 hour

The reaction of aldehyde 2c and DAG was performed in the various protic and aprotic solvents to evaluate the role of the solvent on the reaction. It was found that MeOH and H2O showed good and low yields, respectively, and their mixtures showed less yields than MeOH (Table 2), while no progress was detected in THF or toluene even after 24 h.

Table 2 Solvent effect on the reaction yield for the condensation reaction of DAG and 2c in the presence of p-TSA

In addition, the reaction of 2c and DAG in MeOH/H2O solvent was investigated in the presence of other acids such as H2SO4, CF3SO3H and CH3SO3H as the catalyst (Table 3). It was found that the H2SO4 and CF3SO3H work better than p-TSA in a much shorter period of time while the weaker acid CH3SO3H was found to be unreactive.

Table 3 The effect of various acids on the reaction time and yield

Conclusions

In summary, the present procedure provides an example of green chemistry methodology for the synthesis of 2,5-dihydro-1H-imidazole 3-oxides and 1,4-diazaspiro[4.n]dec-1-ene 1-oxides (n = 4–6) involving an amine and an oxime functional groups at 4 and 5 positions in protic solvent MeOH or H2O/MeOH with high yields within 1–2 h using p-TSA, H2SO4 or CF3SO3H as catalyst. The resulting nitrones are highly potent for the preparation of fused ring heterocyclic compounds by the application of 1,3-dipolar cycloaddition reactions. In addition, the amine and oxime functional groups in the nitrone derivatives can be applied for the generation of new fused ring heterocycles. Therefore, they are expected to find important applications in the synthesis of novel fused ring systems. This proposal is under investigation and the results will be published elsewhere.

In comparison to the previously reported methodology for the preparation of the under-discussion nitrones there are some advantages for the current modification including (1) synthesis of a new class of nitrones with the ketones, (2) application of a green procedure by the usage of H2O as solvent, (3) improvement of the reaction yields, (4) application of mild reaction conditions and (5) avoiding long reaction times. Finally, the effect of the Heat treatment on the stability of the structural isomers of the products has been studied as well.

Experimental

All the reagent and solvents were obtained from Merck (Germany) and were used without further purification. DAG was prepared according to the literature procedure17. Melting points were measured on an Electrothermal 9100 apparatus. Mass spectra were recorded on a FINNIGAN-MAT 8430 mass spectrometer operating at an ionization potential of 70 eV. 1H and 13C NMR spectra were recorded on a Bruker DRX-300 Advance spectrometer at 300.13 and 75.47 MHz, respectively. NMR spectra were obtained in DMSO-d6 using TMS as internal standard.

General procedure for the preparation of nitrones

3,4-Diaminoglyoxime (0.12 g, 1 mmol), benzaldehyde derivatives(1.2 mmol) or ketones (1.2 mmol) and p-toluene sulphonic acid (p-TSA) (0.034 g, 0.2 mmol) were added to a solution of water:methanol (70:30, 5 ml), and the mixture was stirred at room temperature for appropriate time. The progress of the reaction was monitored by TLC (ethyl acetate/n-hexane 7:3). Then, the reaction mixture was filtered off and the precipitate was washed with methanol–water and dried.

4-Amino-5-(hydroxyimino)-2-(4-methylphenyl)-2,5-dihydro-1H-imidazole3-oxide(3a)

(90 %) white solid, mp 209–210 °C; IR (KBr, cm−1): 3,358, 3,242 (NH2), 3,158, 3,097 (OH), 2,883 (CH-Imidazole), 1,716, 1,683 (C=N), 1,602, 1,454 (benzene ring), 1,353 (N=O), 1,226 (C–N), 933,921 (N–O).

Z and E isomer: 1HNMR (250 MHz, DMSO-d 6 ): 3.39 (s, 3H, CH3), 5.60, 5.71 (s, H, CH-Imidazole), 6.34, 6.51 (s, H, NH2), 7.32-7.44 (m, H–Ar), 7.49, 7.76 (s, H, NH), 9.98, 10.20 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 81.2, 93.8, 127.2, 128.0, 129.1, 129.3, 134.2, 137.1, 139.0, 141.9, 144.1, 152.0 ppm.

Z-isomer: 1HNMR (250 MHz, DMSO-d 6 ): 3.39 (s, 3H, CH3), 5.60 (s, H, CH-Imidazole), 6.35 (s, H, NH2), 7.33–7.47 (m, H–Ar), 7.47 (s, H, NH), 10.20 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 94.8, 127.8, 128.6, 129.3, 129.5, 137.6, 139.9, 142.9, 153.0 ppm.

4-Amino-5-(hydroxyimino)-2-phenyl-2,5-dihydro-1H-imidazole 3-oxide (3b)

(83 %) white solid, mp 202–203 °C; IR(KBr, cm−1): 3,355, 3,251 (NH2), 3,183, 3,097 (OH), 2,884 (imidazole C–H), 1,716, 1,682 (C=N), 1,603, 1,458 (benzene ring), 1,360 (N=O), 1,226 (C–N), 933, 921 (N–O); MS: m/e (%) 206 (M+, 10), 189(M-NH3, 9), 161(20), 139(80), 105 (C6H5CHNH, base peak, 100), 77 (90), 69 (40), 65 (50).

Z and E isomer: 1HNMR (250 MHz, DMSO-d 6 ): 5.62, 5.77 (s, H, CH-Imidazole), 6.40, 6.49 (s, H, NH2), 7.30-7.56 (m, H–Ar), 7.57, 7.83 (s, H, NH), 10.02, 10.23 (s, H, NOH) ppm; 13C NMR (62.5 MHz, DMSO-d 6 ): 80.2, 93.8, 126.9, 127.0, 127.2, 128.1, 128.9, 129.2, 129.4, 129.7, 129.9, 131.3, 140.1, 141.9, 145.4, 152 ppm.

Z-isomer: 1HNMR (250 MHz, DMSO-d 6 ): 5.75 (s, H, CH-Imidazole), 6.52 (s, H, NH2), 7.43-7.75 (m, H–Ar), 7.87 (s, H, NH), 10.25 (s, H, NOH) ppm. 13C NMR (62.5 MHz, DMSO-d 6 ): 92.6, 126.6, 127.2, 128.7, 129.1, 129.2, 129.5, 129.9, 132.3, 143.6, 152.3 ppm.

4-Amino-5-(hydroxyimino)-2-(4-methoxyphenyl)-2,5-dihydro-1H-imidazole 3-oxide (3c)

(84 %) white solid, mp 196-198 °C; IR(KBr, cm−1): 3,395, 3,311 (NH2), 3,167, 3,097 (OH), 2,891 (CH-Imidazole), 1,716, 1,694 (C=N), 1,613,1,515 (benzene ring), 1,372 (N=O), 1,248 (C–N), 937,923 (N–O).

Z and E isomer: 1HNMR (250 MHz, DMSO-d 6 ): 3.75, 3.78 (s, 3H, CH3), 5.72, 6.03 (s, H, CH-Imidazole), 6.51, 6.64 (s, H, NH2), 6.96-7.38 (m, H–Ar), 7.38, 7.54 (s, H, NH), 9.94, 10.21 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 55.94, 55.97, 78.9, 88.50, 111.58, 120.68, 127.13, 127.49, 130.81, 130.90, 142.00, 151.83, 153.5, 157.50 ppm.

Z-isomer: 1HNMR (250 MHz, DMSO-d 6 ): 3.76 (s, 3H, CH3), 5.71 (s, H, CH-Imidazole), 6.65 (s, H, NH2), 6.94–7.29 (m, H–Ar), 7.40 (s, H, NH), 10.23 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 55.44, 88.53, 113.54, 121.48, 127.17, 128.49, 130.81, 131.90, 142.20, 152.83, 157.50 ppm.

4-Amino-5-(hydroxyimino)-2-(4-chlorophenyl)-2,5-dihydro-1H-imidazole 3-oxide (3d)

(81 %) white solid, mp 206–207 °C; IR (KBr, cm−1): 3,365, 3,239 (NH2), 3,182 (OH), 2,883 (CH-Imidazole), 1,716, 1,684 (C=N), 1,599, 1,455 (benzene ring), 1,351 (N=O), 1,229 (C–N), 927 (N–O).

Z and E isomer: 1HNMR (250 MHz, DMSO-d 6 ): 5.60, 5.81 (s, H, CH-Imidazole), 6.40, 6.72 (s, H, NH2), 7.86-8.28 (m, H–Ar), 8.14, 8.24 (s, H, NH), 10.41, 10.45 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 80.12, 92.9, 128.4, 128.7, 128.9, 129.0, 129.2, 131.7, 134.1, 134.2, 141.8, 147.5, 148.4, 151.9, 166.4 ppm.

Z-isomer: 1HNMR (250 MHz, DMSO-d 6 ): 5.63 (s, H, CH-Imidazole), 6.42 (s, H, NH2), 7.82–8.23 (m, H–Ar), 8.11 (s, H, NH), 10.36 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 92.9, 128.4, 128.7, 128.9, 129.0 129.4, 1,134.2, 134.5, 142.8, 148.4, 152.9, 167.4 ppm.

4-Amino-5-(hydroxyimino)-2-(2-methoxyphenyl)-2,5-dihydro-1H-imidazole 3-oxide (3e)

(69 %) white solid, mp 196–198 °C; IR(KBr, cm−1): 3,400, 3,264 (NH2), 3,180 (OH), 2,892 (CH-Imidazole), 1,709, 1,687 (C=N), 1,687,1,469 (benzene ring), 1,348 (N=O), 1,220 (C–N), 931 (N–O).

Z and E isomer: 1HNMR (250 MHz, DMSO-d 6 ): 3.77, 3.79 (s, 3H, CH3), 5.49, 5.66 (s, H, CH-Imidazole), 6.04, 6.66 (s, H, NH2), 6.98–7.05 (m, H–Ar), 7.23, 7.31 (s, H, NH), 10.13, 10.17 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 55.11, 79.1, 88.5, 111.6, 120.6, 127.2, 127.5, 130.8, 142.0, 151.8, 157.5 ppm.

Z-isomer: 1HNMR (250 MHz, DMSO-d 6 ): 3.79 (s, 3H, CH3), 5.51 (s, H, CH-Imidazole), 6.64 (s, H, NH2), 6.95-7.04 (m, H–Ar), 7.33 (s, H, NH), 10.14 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 55.11, 88.5, 111.6, 120.6, 125.3, 127.2, 127.5, 128.2, 130.8, 131.0, 142.0, 148.2, 151.8, 153.3, 157.5 ppm.

4-Amino-2-(5-bromo-2-hydroxyphenyl)-5-(hydroxyimino)-2,5-dihydro-1H-imidazole 3-oxide (3f)

(62 %) white solid, mp 173–175 °C; IR(KBr, cm−1): 3,329, 3,285 (NH2), 3,188 (OH), 2,912 (CH-Imidazole), 1,715, 1,685 (C=N), 1,594, 1,495 (benzene ring), 1,354 (N=O), 1,226 (C–N), 934 (N–O).

Z and E isomer: 1HNMR (250 MHz, DMSO-d 6 ): 5.63, 5.97 (s, H, CH-Imidazole), 6.24, 6.36 (s, H, NH2), 7.94–8.72 (m, H–Ar, NH), 10.21, 10.35 (s, H, NOH), 12.94, 13.26 (s, 1H, OH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 56.50, 84.6, 93.7, 116.7, 118.51, 120.12, 121.42, 126.5, 128.7, 129.3, 130.7, 131.9, 142.0, 152.0, 159.4, 161.13 ppm.

Z-isomer: 1HNMR (250 MHz, DMSO-d 6 ): 5.95 (s, H, CH-Imidazole), 6.37 (s, H, NH2), 7.86–8.68 (m, H–Ar, NH), 10.35 (s, H, NOH), 13.26 (s, 1H, OH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 56.61, 93.7, 128.7, 129.3, 131.9, 142.0, 152.0, 159.4 ppm.

4-Amino-5-(hydroxyimino)-2-(2-cholorophenyl)-2,5-dihydro-1H-imidazole 3-oxide (3 g)

(70 %) white solid, mp 205–207 °C; IR(KBr, cm−1): 3,364, 3,241 (NH2), 3,184 (OH), 2,883 (CH-Imidazole), 1,715, 1,682 (C=N), 1,600,1,458 (benzene ring), 1,353 (N=O), 1,231 (C–N), 931 (N–O).

Z-isomer: 1HNMR (250 MHz, DMSO-d 6 ): 6.17 (s, H, CH-Imidazole), 7.28 (s, H, NH2), 7.40–7.46 (m, H–Ar), 8.14 (s, H, NH), 10.24 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 78.1, 127.9, 130.2, 130.4, 131.4, 133.7, 134.0, 139.3, 145.2 ppm.

4-Amino-5-(hydroxyimino)-2-(3-methoxyphenyl)-2,5-dihydro-1H-imidazole 3-oxide(3 h)

(71 %) white solid, mp 197–199 °C; IR(KBr, cm−1): 3,400, 3,264 (NH2), 3,180 (OH), 2,892 (CH-Imidazole), 1,709, 1,687 (C=N), 1,687,1,469 (benzene ring), 1,348 (N=O), 1,220 (C–N), 931 (N–O).

Z-isomer: 1HNMR (250 MHz, DMSO-d 6 ): 3.78 (s, 3H, CH3), 5.59 (s, H, CH-Imidazole), 6.38 (s, H, NH2), 6.90–7.06 (m, H–Ar), 7.53 (s, H, NH), 10.2 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 56.3, 93.6, 112.5, 114.9, 115.2, 120.1, 129.8, 130.0, 141.9, 158.8 ppm.

4-Amino-5-(hydroxyimino)-2-methyl-2,5-dihydro-1H-imidazole 3-oxide (3i)

(65 %) yellow solid, mp 237–239 °C; 1HNMR (250 MHz, DMSO-d 6 ): 1.32–1.34 (d, 3H, CH3), 3.36 (q, H, CH-Imidazole), 6.32 (s, H, NH2), 7.24 (s, H, NH), 9.91 (s, H, NOH) ppm.

2-Amino-3-(hydroxyimino)-1,4-diazaspiro[4.4]non-1-ene 1-oxide(5a)

(90 %) white solid, mp 216 °C; IR (KBr, cm−1): 3,443, 3,324, 3,185, 1,714, 1,684, 1,466, 1,330, 1,193, 1,036, 959. 746. Z and E isomer: 1HNMR (250 MHz, DMSO-d 6 ): 1.57–1.73 (m, 8H, Cyclopentane), 5.49, 6.38 (s, 2H, NH2), 7.14, 7.85 (s, H, NH), 9.92, 10.11 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 23.4, 25.1, 36.9, 38.2, 91.0, 107.5, 136.4, 142.3, 144.4, 151.0 ppm.

Z-isomer: 1HNMR (250 MHz, DMSO-d 6 ): 1.57–1.73 (m, 8H, Cyclopentane), 6.39 (s, 2H, NH2), 7.85 (s, H, NH), 9.92 (s, H, NOH), ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 24.5, 36.3, 90.5, 136.0, 143.9 ppm.

2-Amino-3-(hydroxyimino)-1,4-diazaspiro[4.5]dec-1-ene-1-oxide(5b)

(95 %) white solid, mp 208–210 °C; IR (KBr, cm−1): 3,318, 3,189, 2,933, 2,867, 2,796, 1,712, 1,695, 1,614, 1,455, 1,383, 1,315, 1,251, 1,167, 936, 753.

Z and E isomer: 1HNMR (250 MHz, DMSO-d 6 ): 1.19–1.67 (m, 10H, Cyclohexane) 5.47, 6.25 (s, 2H, NH2), 6.94, 7.76 (s, H, NH), 9.91, 10.07 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 21.2, 22.4, 24.1, 24.3, 34.7, 35.8, 83.2, 97.6, 135.5, 141.8, 143.7, 150.5 ppm.

Z-isomer: 1HNMR (250 MHz, DMSO-d 6 ): 1.19-2.08 (m, 10H, cyclohexane) 5.47 (s, 2H, NH2), 6.94 (s, H, NH), 10.04 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 22.4, 24.3, 35.8, 97.6, 141.8, 150.5 ppm.

2-Amino-3-(hydroxyimino)-1, 4-diazaspiro[4.6]undec-1-ene-1-oxide (5c)

(88 %) white solid, mp 163 °C; IR (KBr, cm−1): 3,374, 3,152, 2,923, 1,684, 1,574, 1,459, 1,317, 1,273, 1,205, 945, 912, 746.

Z and E isomer: 1HNMR (250 MHz, DMSO-d 6 ): 1.52–2.16 (m, 12H, Cycloheptane), 5.45, 6.23 (s, 2H, NH2), 7.06, 7.77 (s, H, NH), 9.87, 10.05 (s, H, NOH) ppm. 13CNMR (62.5 MHz, DMSO-d 6 ): 21.3, 21.8, 29.0, 29.7, 39.5, 39.6, 80.5, 101.8, 125.5, 141.9, 144.6, 150.4 ppm.

Z-isomer: 1HNMR (250 MHz, DMSO-d 6 ): 1.61–2.32 (m, 12H, Cycloheptane), 6.26(s, 2H, NH2), 7.79 (s, H, NH), 10.06 (s, H, NOH) ppm. 13CNMR (62.5 MHz, DMSO-d 6 ): 21.8, 29.7, 39.5, 101.8, 141.9, 150.4 ppm.

2-Amino-8-tert-butyl-3-(hydroxyimino)-1, 4-diazaspiro[4.5]dec-1-ene 1-oxide(5d)

(92 %) white solid, mp 220 °C; IR (KBr, cm−1): 3,585, 3,257, 2,954, 2,867, 1,690, 1,478, 1,368, 1,304, 1,249, 1,194, 1,133, 946, 748.

Z and E isomer: 1HNMR (250 MHz, DMSO-d 6 ): 0.84, 0.86 (s, 9H, m, Tert-butyl), 1.28 (p, 1H,CH-cyclohexane), 1.32–2.00 (m, 8H, Cyclohexane), 5.84, 6.27 (s, 2H, NH2), 7.35, 7.96 (s, H, NH), 9.86, 10.03 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 18.11, 23.28, 27.43, 27.58, 32.12, 36.04, 36.19, 36.70, 38.40, 81.04, 99.25, 136.02, 138.8, 146.01, 150.16 ppm.

Z-isomer: 1HNMR (250 MHz, DMSO-d 6 ): 0.88 (s, 9H, m, Tert-butyl), 1.43 (p, 1H, cyclohexane), 1.39–2.11 (m, 8H, Cyclohexane), 6.43 (s, 2H, NH2), 8.03 (s, H, NH), 10.12 (s, H, NOH) ppm.

4-Amino-5-(hydroxyimino)-2,2-dimethyl-2,5-dihydro-1H-imidazole 3- oxide(5e)

(85 %) white solid, mp 217 °C; IR(KBr, cm−1): 3,460, 3,357, 3,187, 2,765, 1,695, 1,636, 1,439, 1,315, 1,191, 947, 718. Z and E isomer: 1HNMR (250 MHz, DMSO-d 6 ): 1.35 (s, 6H, CH3), 5.48, 6.24 (s, 2H, NH2), 6.96, 7.59 (s, H, NH), 9.85, 10.12 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 25.9, 26.5, 81.0, 97.0, 135.0, 141.8, 143.9, 150.5 ppm.

Z-isomer: 1HNMR (250 MHz, DMSO-d 6 ): 1.39 (s, 6H, CH3), 6.34 (s, 2H, NH2), 7.64 (s, H, NH), 10.16 (s, H, NOH) ppm; 13CNMR (62.5 MHz, DMSO-d 6 ): 26.1, 97.3, 142.0, 150.8 ppm.